Merck & Co.’s HPV vaccine Gardasil appears headed into a sales slump in China, and the country’s ongoing crackdown on corruption in healthcare could be a factor in the decline.
Gardasil is the firm’s second-biggest seller, and China is a key growth market for vaccine, so the stumble was a...







